We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Invited Critique |

Comparison of Percutaneous and Surgical Approaches for Radiofrequency Ablation of Small and Medium Hepatocellular Carcinoma—Invited Critique

Michael E. deVera, MD; James W. Marsh, MD; T. Clark Gamblin, MD
Arch Surg. 2007;142(12):1143. doi:10.1001/archsurg.142.12.1143.
Text Size: A A A
Published online


Khan et al are to be commended for their results using RFA, either percutaneously or surgically, for the treatment of small (≤ 3 cm) and medium (3.1-5 cm) HCC. Their local ablation rate of 92% to 95% using either approach is a testimony to their experience with this modality. They demonstrate that RFA using either approach is equally effective for small lesions, in line with the experience of other groups.1,2 However, notwithstanding their improved results using a surgical approach, it remains to be seen whether RFA will be as effective for medium tumors. The treatment of HCC requires a multidisciplinary team, such as the Khan et al group, that can provide multimodal forms of therapy, including liver transplantation, an option that, although limited in availability, offers the best chance for a cure in patients with early-stage HCC. Despite the best efforts of Khan et al, their 3-year disease-free survival rates for both techniques, 22% to 33% and 0% to 19% for small and medium lesions, respectively, clearly demonstrate that RFA alone is not an effective primary treatment for HCC. The problem, of course, is not due to treatment failures but rather the development of new lesions elsewhere in the liver or metastasis, indicating that even in the setting of early HCC, RFA addresses neither the problem of new lesions developing in a background of chronic liver inflammation or cirrhosis nor the inherent biological potential of most lesions to spread hematogenously. The role of RFA in the treatment of early-stage HCC continues to be defined (there are ongoing prospective randomized studies assessing whether RFA is just as effective as hepatic resection for small tumors) and evolve, but its use must be guided by the sobering reality that HCC is almost never just a localized disease.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles